68
Participants
Start Date
November 13, 2020
Primary Completion Date
April 17, 2023
Study Completion Date
December 22, 2023
Suramin
Suramin is administered via IV infusion as a single dose of 3 mg/kg
Placebo
Placebo
New York-Presbyterian Medical Center of Queens, Flushing
Emory Johns Creek Hospital, Johns Creek
Emory University School of Medicine, Atlanta
Southeast Renal Research Institute, Chattanooga
University of Kentucky, Lexington
University of Missouri - Dept. of Surgery, Columbia
University of Arkansas Medical Sciences (UAMS), Little Rock
Baylor Scott and White Research Institute - Dallas Clinical Trials Office, Dallas
University of New Mexico Health Science Center, Albuquerque
California Institute of Renal Research, La Mesa
Ronald Reagan UCLA Medical Center, Los Angeles
Wake Forest Baptist Medical Center, Winston-Salem
Lead Sponsor
Rediscovery Life Sciences
INDUSTRY